Cargando…
Therapeutic Development and Drugs for the Treatment of COVID-19
SARS-CoV-2/novel coronavirus (2019-nCoV) is a new strain that has recently been confirmed in Wuhan City, Hubei Province of China, and spreads to more than 165 countries of the world including India. The virus infection leads to 245,922 confirmed cases and 10,048 deaths worldwide as of March 20, 2020...
Autores principales: | Maurya, Vimal K., Kumar, Swatantra, Bhatt, Madan L. B., Saxena, Shailendra K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189400/ http://dx.doi.org/10.1007/978-981-15-4814-7_10 |
Ejemplares similares
-
Current Insight into the Novel Coronavirus Disease 2019 (COVID-19)
por: Saxena, Shailendra K., et al.
Publicado: (2020) -
Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor
por: Maurya, Vimal K., et al.
Publicado: (2020) -
Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)
por: Kumar, Swatantra, et al.
Publicado: (2020) -
Progress and Challenges Toward Generation and Maintenance of Long-Lived Memory T Lymphocyte Responses During COVID-19
por: Kumar, Swatantra, et al.
Publicado: (2022) -
Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: Kumar, Swatantra, et al.
Publicado: (2020)